Page last updated: 2024-08-21

benzoxazoles and cb-839

benzoxazoles has been researched along with cb-839 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Badawi, RD; Cherry, SR; Dunphy, M; Frankel, P; Gandara, DR; Gonsalves, WI; Kunos, C; Lanza, I; Lara, PN; Nardo, L; Newman, E; Paik, PK; Reid, J; Riess, JW; Shackelford, D	1

Trials

1 trial(s) available for benzoxazoles and cb-839

Article	Year
Phase 1 Trial of MLN0128 (Sapanisertib) and CB-839 HCl (Telaglenastat) in Patients With Advanced NSCLC (NCI 10327): Rationale and Study Design. Clinical lung cancer, 2021, Volume: 22, Issue:1 Topics: Adenocarcinoma of Lung; Antineoplastic Combined Chemotherapy Protocols; Benzeneacetamides; Benzoxazoles; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase I as Topic; Humans; Lung Neoplasms; Prognosis; Pyrimidines; Thiadiazoles	2021

Article

Year

Phase 1 Trial of MLN0128 (Sapanisertib) and CB-839 HCl (Telaglenastat) in Patients With Advanced NSCLC (NCI 10327): Rationale and Study Design.

Clinical lung cancer, 2021, Volume: 22, Issue:1

Topics: Adenocarcinoma of Lung; Antineoplastic Combined Chemotherapy Protocols; Benzeneacetamides; Benzoxazoles; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase I as Topic; Humans; Lung Neoplasms; Prognosis; Pyrimidines; Thiadiazoles

2021